UPS has opened 27 new temperature-controlled cross-dock facilities globally to meet the escalating demand for precise cold-chain logistics in the pharmaceutical and biotech industries. These facilities are designed for rapid transfers and adhere to pharmaceutical handling standards. This development highlights the growing need for robust supply chain management solutions and secure, temperature-controlled transit, crucial for high-value, sensitive goods.
Read the full article at FreightWaves
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





